Geopolitical instability impacting global business
Management highlighted geopolitical risks as a key concern given the company's international presence, though diversification mitigates impact.
medium · management_commentaryAlivus Life Sciences Limited — Q3 FY26
Alivus Life Sciences reported its highest-ever quarterly revenue of ₹673 crore, up 4.8% YoY, driven by a strong CDMO recovery (85.3% YoY growth) and robust non-GPL business grow...
bullish
high
Financial stats pending filing verification
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
CDMO growth slower than peers due to smaller deal sizes
Analyst questioned why CDMO deal sizes are limited to $4-6M vs peers targeting $50-100M; management defended strategy citing high attrition and tax-driven manufacturing in Ireland.
medium · analyst_questionPricing erosion in mature molecules
Management acknowledged 4-4.5% annual price erosion across the portfolio, but expects to offset via next-gen processes and new launches.
low · management_commentarySholapur capacity delay and scale-down
Sholapur plant delayed by ~3 months to July 2026, and initial capacity reduced from 600kL to 450-500kL, though management says it won't impact growth.
low · data_observation